Triwise Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Triwise capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Triwise Capital Today - Breaking & Trending Today

Heranova Lifesciences Debuts with $13.5 Million Seed and Seed+ Round Funding to Offer Integrated Clinical Solutions to Women's Health

BOSTON and HONG KONG, Dec. 28, 2023 /PRNewswire/ Heranova Lifesciences Holding Ltd. ("Heranova") today announced the successful completion of a USD 13.5 ....

United States , Hugh Taylor , Heranova Lifesciences , Farideh Bischoff , Yikai Xu , Women Health , Technology Partners , Heranova Lifesciences Holding Ltd , Heranova Lifesciences Holding , Venture Partners China , Sinovation Ventures , Emerging Technology Partners , Triwise Capital , Yale New Haven Hospital , Scientific Advisory , Chief Diagnostic Medical Officer , Thailand Business ,

Women's health company Heranova Lifesciences launches with $13.5M

The company offers diagnostic tests and therapeutics to detect and treat endometriosis, female fertility and bacterial vaginosis. ....

Heranova Lifesciences , Farideh Bischoff , Indiana Health , Biron Health , Technology Partners , Boston Based Heranova Lifesciences , Venture Partners China , Sinovation Ventures , Triwise Capital , Maven Clinic ,

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Francisco Bay , United States , Palo Alto , Christopher Whitmore , Austinl Gurney , Charlene Liao , Tara Cooper , Barbaraj Klencke , Regeneron Pharmaceuticals Inc , California Institute For Regenerative Medicine , National Cancer Institute , Grace Communication Group , National Institutes Of Health , Onc Therapeutics Inc , Drug Administration , Leukemia Lymphoma Society Therapy Acceleration Program , Annual Healthcare , Onc Therapeutics , Triwise Capital , Proxima Ventures , Lymphoma Society , Therapy Acceleration Program , Wuxi Biologics Healthcare , Corporate Highlights , Drug Evaluation , China National Medical Products Administration ,

Adlai Nortye Raises $100 Million in Series D Financing

Adlai Nortye Raises $100 Million in Series D Financing
Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures
BriefingWire.com, 7/15/2021 -
NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as Adlai Nortye ), a global biopharmaceutical company focused on developing innovative oncology dr gs, today announced the completion of $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing is participated by Legend Star, Wuxi Biologicals Healthcare Ventures, Triwise Capital, Qingdao Mukui, Guolian Industrial Investment, Tian Ge Interactive, etc. Proceeds from the financing will be used to accelerate the development of ongoing clinical and preclinical programs, expand dr g portfolio through in-house R&D capability ....

Ryan Leng , Carsten Lu , Adlai Nortye , Fund Managemengt , Adlai Nortye Ltd , Fund Management , Nortye Raises , Seriesd Financing , Legend Star , Wuxi Biologics Healthcare , Wuxi Biologicals Healthcare Ventures , Triwise Capital , Qingdao Mukui , Guolian Industrial Investment , Tian Ge Interactive , Managing Director , கார்ஸ்டன் லு , நிதி மேலாண்மை , புராண நட்சத்திரம் , டியாந் கே ஊடாடும் , நிர்வகித்தல் இயக்குனர் ,

Adlai Nortye Raises $100 Million in Series D Financing, Co-led by SDIC Fund Management and Tigermed, participated by Legend Star, WuXi Biologics Healthcare Ventures

(1)
NEW JERSEY and HANGZHOU, CHINA, July 15, 2021 - (ACN Newswire) - Adlai Nortye Ltd. (hereinafter referred to as Adlai Nortye ), a global biopharmaceutical company focused on developing innovative oncology drugs, today announced the completion of $100 million Series D financing round. Co-led by SDIC Fund Management and Tigermed, this round of financing is participated by Legend Star, Wuxi Biologicals Healthcare Ventures, Triwise Capital, Qingdao Mukui, Guolian Industrial Investment, Tian Ge Interactive, etc. Proceeds from the financing will be used to accelerate the development of ongoing clinical and preclinical programs, expand drug portfolio through in-house R&D capability, in-licensing, mergers and acquisitions and other strategic collaborations. ....

United States , Ryan Leng , Carsten Lu , Asia Pacific , Adlai Nortye , Fund Managemengt , Oncolytics Biotech , Adlai Nortye Ltd , Fund Management Corporation , Fund Management , Legend Star , Wuxi Biologicals Healthcare Ventures , Triwise Capital , Qingdao Mukui , Guolian Industrial Investment , Tian Ge Interactive , Managing Director , Management Corporation Limited , South America , Hong Kong Listed , Wuxi Biologics , ஒன்றுபட்டது மாநிலங்களில் , கார்ஸ்டன் லு , ஆசியா பெஸிஃபிக் , நிதி மேலாண்மை நிறுவனம் , நிதி மேலாண்மை ,